Recently adopted names for antineoplastics

Name	Code name	Type	Target(s)
abexinostat	PCI-24781, S-78454, PCI-24781-01, S-78454-1, CRA-024781-HCl, CRA-024781-01	synthetic small molecule	Histone deacetylase(s)
alisertib	MLN-8237	synthetic small molecule	Aurora A kinase, Aurora B kinase
cabozantinib	XL-184, BMS-907351	synthetic small molecule	MET RET VEGFR1 VEGFR2 VEGFR3
calaspargase pegol (asparaginase)	EZN-2285	enzyme
crenolanib	ARO-002; CP-868,596	synthetic small molecule	PDGFR
dabrafenib	GSK-2118436A	synthetic small molecule	MEK
dalantercept	ACE-041	protein	TGF-beta family
delanzomib	CEP-18770, CT-47098, NPH-007098	synthetic small molecule	Proteasome
erismodegib	LDE-225	synthetic small molecule	Smoothened (SMO)
ficlatuzumab	SCH-900105, AV-299	monoclonal antibody	Hepatocyte growth factor
galeterone	TOK-001, VN-124	natural product-derived small molecule	Androgen receptor (AR)
macitentan	ACT-064992	synthetic small molecule	Endothelin receptor A, endothelin receptor B
rucaparib	AG-14699, AG-014699, PF-01367338, AG-14447	synthetic small molecule	Poly (ADP-ribose) polymerase (PARP)
sepantronium	YM-155	synthetic small molecule	BIRC5 baculoviral IAP repeat containing 5  (BIRC5)
sitaxentan	TBC-11251z, TBC-11251Na	synthetic small molecule	Endothelin receptor A, endothelin receptor B
trametinib	GSK-1120212	synthetic small molecule	MEK
volasertib	BI-6727	synthetic small molecule	Polo-like kinase 1 (PLK1)